Latest Changes

Title Description Major Minor Date
EUCAST SOP 9.0 EUCAST SOP 9.0 Procedure for establishing zone diameter breakpoints and quality control criteria for new antimicrobial agents The EUCAST SOP 9.0 describes the EUCAST procedure for establishing zone diameter breakpoints and quality control criteria for new antimicrobial agents. 2014/11/05
EUCAST Development and Network Laboratories The EUCAST methods for susceptibility testing of bacteria and fungi requires the lead of two dedicated laboratories and the help of many others. How this works is described in documents on Development and Network Laboratories. 2014/11/04
MIC-testing offered The EUCAST Development Laboratory offers to perform MIC testing on bacteria using broth microdilution quality controlled to the highest standard. 2014/11/04
Ceftaroline rational document published 2014/10/12
EUCAST QC Table v 4.0 published 5 Sept 2014 Information 2014-09-05: The EUCAST QC table v 4.0 (2014-09-05) - the most important changes and additions are: - MIC ranges for amoxicillin-clavulanic acid and ampicillin-sulbactam validated for testing with fixed inhibitor concentrations - MIC ranges for ceftobiprole - Zone diameter range for E. coli ATCC 25922 and pefloxacin 5 µg - New MIC range for S. aureus ATCC 29213 and telavancin with polysorbate-80 - Ranges for E. faecalis ATCC 29212 and ciprofloxacin, levofloxacin and norfloxacin - Tentative MIC ranges for H. influenzae ATCC 49766 2014/09/05
Updated AFST document 9.2 MIC determination in moulds - document 9.1 has been updated to v. 9.2. 2014/08/25
Compliance of manufacturers of AST devices and materials with EUCAST guidelines has been updated 2014/08/15
Updated breakpoint table for antifungal agents (v 7.0) published on 12 August, 2014. The breakpoint table for antifungal agents updated on 12 August 7.0. The table is uppdated on a yearly basis but the publication is not synchronised with the yearly update of the table for antibacterial agents. 2014/08/12
Itraconazole vs. Candida spp rationale document now available The rationale document "Itraconazole vs. Candida spp v 1.0" is published along with comments and replies from the consultation process. 2014/08/02
Addendum: Ceftobiprole and telavancin breakpoints Ceftobiprole breakpoints are now published (will be integrated in the Breakpoint table 5.0) together with revised breakpoints for telavancin (following a revision of methodology for broth microdilution). 2014/07/07
New template for Rationale Documents available 2014/06/26
EUCAST SOP 8 (Format and updating of EUCAST documents) The EUCAST SOP 8.0 is published. It deals with Format and updating of EUCAST documents. 2014/06/26
New version of EUCAST media preparation manual New versions of EUCAST media preparation manual 2014/06/19
New versions of EUCAST disk diffusion manuals EUCAST disk diffusion manuals and reading guides updated 19 June 2014 2014/06/19
AFST Chairperson´s report 2013-14 The report of Maiken Cavling-Arendrup for the AFST Subcommittee activities during 2013-14 is now published. 2014/06/03
EUCAST AFST GC meeting, Barcelona 2014 The minutes from the AFST General Committee meeting in Barcelona 2014, now available. 2014/05/30
Antibiotics/organisms in lacking clinical data EUCAST has been asked to prepare a list of proposals, with priorities, for clinical studies to support/refute current clinical breakpoints where good clinical data supporting the breakpoints are highly desirable but not currently available. 2014/05/14
EUCAST AFST membership changes The description of the EUCAST AFST Subcommittee has been updated 2014/04/21
Consultation on MIC determination of coniiaforming moulds See EUCAST news-flow for consultation document and response form. 2014/04/16
Guidance Document on breakpoints for agents of topical use. A new EUCAST Guidance Document published. 2014/03/30
Czech translations of EUCAST documents Czech translations of EUCAST documents available on the Czech NAC homepage 2014/03/19
The EUCAST Disk Diffusion Test published The EUCAST Disk diffusion test published in CMI. 2014/03/14
New FAQ (updated from March 2013 to February 2014) The FAQ document has undergone a major revision. New questions and answers have been added and other Q&As have been revised. 2014/02/26
EUCAST SOP 7.0 Preparation and handling of minutes. Another EUCAST SOP published. This describes how minutes are prepared and handled inside the organisation of EUCAST. 2014/01/22
EUCAST Breakpoint table v 4.0 released The EUCAST breakpoint table v 4.0 (2014) is now available. Note changes in the screen for ciprofloxacin resistance in Salmonellae, introduction of breakpoints for Corynebacteria, UTI breakpoints for amoxicillinclavulanic acid and much more. All changes marked in yellow. 2013/12/29
Pefloxacin 5 mcg disk to screen for low-level ciprofloxacin resistance in Salmonellae. 2013/12/28
All validation files updated and new files added 2013/12/20
The Spanish NAC, COESANT, is presented The Spanish NAC and its website has been added to the list of NAC presentations. 2013/12/14
Detection of resistance mechanisms v 1.0 published The EUCAST guidline for detection of resistance mechanisms and specific resistances of clinical and/or public health importance v 1.0 is published 2013-12-11. 2013/12/11
Spanish translations of antifungal documents The Spanish NAC (COESANT) has translated two documents on susceptibility testing of yeasts and moulds. 2013/11/25
"Compliance of manufacturers" was updated. The document "Compliance of manufacturers" was updated. 2013/09/09
French translations of documents updated! The documents concern disk diffusion according to EUCAST. 2013/08/30
EUCAST SOP 4 updated EUCAST SOP 4 "EUCAST Committees and subcommittees" updated. 2013/08/19
EUCAST SOP 2 updated The EUCAST SOP on setting breakpoints for new agents was updated. 2013/08/12
Meetings dates updated The list of forthcoming meetings and meetings dates updated. The 2014 postgraduate course in Linz advertised. 2013/07/28
Guidance on Burkholdera cepacia A new EUCAST guidance document: Antimicrobial susceptibility testing of Burkholderia cepacia group organisms. 2013/07/20
EUCAST "Resistance detection" document for consultation. The second round of consultation on the EUCAST guidance document "Detection of resistance mechanisms" starts on the §4th of July. Please have your comments with EUCAST before the 16th of September. 2013/07/14
Updated validation of disk diffusion Updated files describing the validation of the EUCAST disk diffusion method and its breakpoints 2013/07/03
Compliance of manufacturers updated June 26, 2013 Update from Thermofisher 2013/06/26
Updated German documents The German versions of EUCAST disk diffusion test documents and the media preparation document have been updated to v 3.0. 2013/06/21
New version of SOP 1 (setting breakpoints) SOP v 1.0 is replaced by v 1.1 with minor revisions. 2013/06/09
Compliance of manufacturers The EUCAST document "Compliance of manufacturers with EUCAST breakpoints and recommendations" have been updated following new information from Thermofisher on their gradient test. 2013/05/03
EUCAST SOP 6.0 The EUCAST SOP 6.0 on the organisation and maintenance of EUCAST websites is published. 2013/05/02
The FAQ document has been updated The FAQ document has been updated with some 15-20 new questions and answers. 2013/04/24
EUCAST methods documents updated! Documents on Media preparation, Manual for disk diffusion, Reading Guide and Slideshow have all been updated. 2013/04/24
Copyright statement amended The Copyright statement has been amended to include the fact that much of what is available on the EUCAST website was produced by EUCAST while under ECDC service contract. 2013/03/19
Compliance of manufacturers updated The table describing the compliance of manufacturers with EUCAST recommendations has been updated. Information on gradient tests has been added. 2013/03/18
Antifungal breakpoint tables - errata corrected A few erratas were discovered in the Antifungal breakpoint tables v 6.0 (March 1, 2013). These are corrected in v 6.1 (March 11, 2013) 2013/03/11
New version (6.0) of the antifungal breakpoint table Antifungal breakpoints have been added to and revised. (v 6.0) 2013/03/01
Anidulafungin rationale document v 2.0 Anidulafungain rationale document v 2.0 and comments during consultation published. 2013/02/27